The global market for Natamycin was estimated to be worth US$ 186 million in 2023 and is forecast to a readjusted size of US$ 288.6 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030

Natamycin - Market

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.

North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.

In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Natamycin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Natamycin by region & country, by Type, and by Application.

The Natamycin market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natamycin.

Market Segmentation

Scope of Natamycin - Market Report

Report Metric	Details
Report Name	Natamycin - Market
Forecasted market size in 2030	US$ 288.6 million
CAGR	6.4%
Forecasted years	2024 - 2030
Segment by Type:	Glucose-based Lactose-based Sodium chloride-based
Segment by Application	Food Medical Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Natamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Natamycin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Natamycin - Market size in 2030?

Ans: The Natamycin - Market size in 2030 will be US$ 288.6 million.

What is the market share of major companies in Natamycin - Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Natamycin - Market report?

Ans: The main players in the Natamycin - Market are Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome

What are the Application segmentation covered in the Natamycin - Market report?

Ans: The Applications covered in the Natamycin - Market report are Food, Medical, Others

What are the Type segmentation covered in the Natamycin - Market report?

Ans: The Types covered in the Natamycin - Market report are Glucose-based, Lactose-based, Sodium chloride-based

1 Market Overview

1.1 Natamycin Product Introduction

1.2 Global Natamycin Market Size Forecast

1.2.1 Global Natamycin Sales Value (2019-2030)

1.2.2 Global Natamycin Sales Volume (2019-2030)

1.2.3 Global Natamycin Sales Price (2019-2030)

1.3 Natamycin Market Trends & Drivers

1.3.1 Natamycin Industry Trends

1.3.2 Natamycin Market Drivers & Opportunity

1.3.3 Natamycin Market Challenges

1.3.4 Natamycin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Natamycin Players Revenue Ranking (2023)

2.2 Global Natamycin Revenue by Company (2019-2024)

2.3 Global Natamycin Players Sales Volume Ranking (2023)

2.4 Global Natamycin Sales Volume by Company Players (2019-2024)

2.5 Global Natamycin Average Price by Company (2019-2024)

2.6 Key Manufacturers Natamycin Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Natamycin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Natamycin

2.9 Natamycin Market Competitive Analysis

2.9.1 Natamycin Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Natamycin Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Glucose-based

3.1.2 Lactose-based

3.1.3 Sodium chloride-based

3.2 Global Natamycin Sales Value by Type

3.2.1 Global Natamycin Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Natamycin Sales Value, by Type (2019-2030)

3.2.3 Global Natamycin Sales Value, by Type (%) (2019-2030)

3.3 Global Natamycin Sales Volume by Type

3.3.1 Global Natamycin Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Natamycin Sales Volume, by Type (2019-2030)

3.3.3 Global Natamycin Sales Volume, by Type (%) (2019-2030)

3.4 Global Natamycin Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Food

4.1.2 Medical

4.1.3 Others

4.2 Global Natamycin Sales Value by Application

4.2.1 Global Natamycin Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Natamycin Sales Value, by Application (2019-2030)

4.2.3 Global Natamycin Sales Value, by Application (%) (2019-2030)

4.3 Global Natamycin Sales Volume by Application

4.3.1 Global Natamycin Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Natamycin Sales Volume, by Application (2019-2030)

4.3.3 Global Natamycin Sales Volume, by Application (%) (2019-2030)

4.4 Global Natamycin Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Natamycin Sales Value by Region

5.1.1 Global Natamycin Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Natamycin Sales Value by Region (2019-2024)

5.1.3 Global Natamycin Sales Value by Region (2025-2030)

5.1.4 Global Natamycin Sales Value by Region (%), (2019-2030)

5.2 Global Natamycin Sales Volume by Region

5.2.1 Global Natamycin Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Natamycin Sales Volume by Region (2019-2024)

5.2.3 Global Natamycin Sales Volume by Region (2025-2030)

5.2.4 Global Natamycin Sales Volume by Region (%), (2019-2030)

5.3 Global Natamycin Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Natamycin Sales Value, 2019-2030

5.4.2 North America Natamycin Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Natamycin Sales Value, 2019-2030

5.5.2 Europe Natamycin Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Natamycin Sales Value, 2019-2030

5.6.2 Asia Pacific Natamycin Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Natamycin Sales Value, 2019-2030

5.7.2 South America Natamycin Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Natamycin Sales Value, 2019-2030

5.8.2 Middle East & Africa Natamycin Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Natamycin Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Natamycin Sales Value

6.2.1 Key Countries/Regions Natamycin Sales Value, 2019-2030

6.2.2 Key Countries/Regions Natamycin Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Natamycin Sales Value, 2019-2030

6.3.2 United States Natamycin Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Natamycin Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Natamycin Sales Value, 2019-2030

6.4.2 Europe Natamycin Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Natamycin Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Natamycin Sales Value, 2019-2030

6.5.2 China Natamycin Sales Value by Type (%), 2023 VS 2030

6.5.3 China Natamycin Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Natamycin Sales Value, 2019-2030

6.6.2 Japan Natamycin Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Natamycin Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Natamycin Sales Value, 2019-2030

6.7.2 South Korea Natamycin Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Natamycin Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Natamycin Sales Value, 2019-2030

6.8.2 Southeast Asia Natamycin Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Natamycin Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Natamycin Sales Value, 2019-2030

6.9.2 India Natamycin Sales Value by Type (%), 2023 VS 2030

6.9.3 India Natamycin Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Danisco

7.1.1 Danisco Company Information

7.1.2 Danisco Introduction and Business Overview

7.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Danisco Natamycin Product Offerings

7.1.5 Danisco Recent Development

7.2 DSM

7.2.1 DSM Company Information

7.2.2 DSM Introduction and Business Overview

7.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.2.4 DSM Natamycin Product Offerings

7.2.5 DSM Recent Development

7.3 VGP

7.3.1 VGP Company Information

7.3.2 VGP Introduction and Business Overview

7.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.3.4 VGP Natamycin Product Offerings

7.3.5 VGP Recent Development

7.4 Handary

7.4.1 Handary Company Information

7.4.2 Handary Introduction and Business Overview

7.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Handary Natamycin Product Offerings

7.4.5 Handary Recent Development

7.5 AMTECH BIOTECH

7.5.1 AMTECH BIOTECH Company Information

7.5.2 AMTECH BIOTECH Introduction and Business Overview

7.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.5.4 AMTECH BIOTECH Natamycin Product Offerings

7.5.5 AMTECH BIOTECH Recent Development

7.6 Silver-Elephant

7.6.1 Silver-Elephant Company Information

7.6.2 Silver-Elephant Introduction and Business Overview

7.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Silver-Elephant Natamycin Product Offerings

7.6.5 Silver-Elephant Recent Development

7.7 Lanzhou Weiri

7.7.1 Lanzhou Weiri Company Information

7.7.2 Lanzhou Weiri Introduction and Business Overview

7.7.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Lanzhou Weiri Natamycin Product Offerings

7.7.5 Lanzhou Weiri Recent Development

7.8 Langfang Meihua

7.8.1 Langfang Meihua Company Information

7.8.2 Langfang Meihua Introduction and Business Overview

7.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Langfang Meihua Natamycin Product Offerings

7.8.5 Langfang Meihua Recent Development

7.9 Zhengzhou New Frey

7.9.1 Zhengzhou New Frey Company Information

7.9.2 Zhengzhou New Frey Introduction and Business Overview

7.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Zhengzhou New Frey Natamycin Product Offerings

7.9.5 Zhengzhou New Frey Recent Development

7.10 Chihon

7.10.1 Chihon Company Information

7.10.2 Chihon Introduction and Business Overview

7.10.3 Chihon Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Chihon Natamycin Product Offerings

7.10.5 Chihon Recent Development

7.11 Jiaozuo Joincare

7.11.1 Jiaozuo Joincare Company Information

7.11.2 Jiaozuo Joincare Introduction and Business Overview

7.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Jiaozuo Joincare Natamycin Product Offerings

7.11.5 Jiaozuo Joincare Recent Development

7.12 Beijing Oriental Rada

7.12.1 Beijing Oriental Rada Company Information

7.12.2 Beijing Oriental Rada Introduction and Business Overview

7.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Beijing Oriental Rada Natamycin Product Offerings

7.12.5 Beijing Oriental Rada Recent Development

7.13 Pucheng Lifecome

7.13.1 Pucheng Lifecome Company Information

7.13.2 Pucheng Lifecome Introduction and Business Overview

7.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Pucheng Lifecome Natamycin Product Offerings

7.13.5 Pucheng Lifecome Recent Development

8 Industry Chain Analysis

8.1 Natamycin Industrial Chain

8.2 Natamycin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Natamycin Sales Model

8.5.2 Sales Channel

8.5.3 Natamycin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Beijing Oriental Rada

Pucheng Lifecome

List of Tables

Table 1. Natamycin Market Trends

Table 2. Natamycin Market Drivers & Opportunity

Table 3. Natamycin Market Challenges

Table 4. Natamycin Market Restraints

Table 5. Global Natamycin Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Natamycin Revenue Market Share by Company (2019-2024)

Table 7. Global Natamycin Sales Volume by Company (2019-2024) & (MT)

Table 8. Global Natamycin Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Natamycin Price by Company (2019-2024) & (USD/MT)

Table 10. Key Manufacturers Natamycin Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Natamycin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Natamycin

Table 13. Global Natamycin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Natamycin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Natamycin Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Natamycin Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Natamycin Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Natamycin Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Natamycin Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)

Table 22. Global Natamycin Sales Volume by Type (2019-2024) & (MT)

Table 23. Global Natamycin Sales Volume by Type (2025-2030) & (MT)

Table 24. Global Natamycin Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Natamycin Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Natamycin Price by Type (2019-2024) & (USD/MT)

Table 27. Global Natamycin Price by Type (2025-2030) & (USD/MT)

Table 28. Global Natamycin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Natamycin Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Natamycin Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Natamycin Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Natamycin Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Natamycin Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)

Table 34. Global Natamycin Sales Volume by Application (2019-2024) & (MT)

Table 35. Global Natamycin Sales Volume by Application (2025-2030) & (MT)

Table 36. Global Natamycin Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Natamycin Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Natamycin Price by Application (2019-2024) & (USD/MT)

Table 39. Global Natamycin Price by Application (2025-2030) & (USD/MT)

Table 40. Global Natamycin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Natamycin Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Natamycin Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Natamycin Sales Value by Region (2019-2024) & (%)

Table 44. Global Natamycin Sales Value by Region (2025-2030) & (%)

Table 45. Global Natamycin Sales Volume by Region (MT): 2019 VS 2023 VS 2030

Table 46. Global Natamycin Sales Volume by Region (2019-2024) & (MT)

Table 47. Global Natamycin Sales Volume by Region (2025-2030) & (MT)

Table 48. Global Natamycin Sales Volume by Region (2019-2024) & (%)

Table 49. Global Natamycin Sales Volume by Region (2025-2030) & (%)

Table 50. Global Natamycin Average Price by Region (2019-2024) & (USD/MT)

Table 51. Global Natamycin Average Price by Region (2025-2030) & (USD/MT)

Table 52. Key Countries/Regions Natamycin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Natamycin Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Natamycin Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Natamycin Sales Volume, (2019-2024) & (MT)

Table 56. Key Countries/Regions Natamycin Sales Volume, (2025-2030) & (MT)

Table 57. Danisco Company Information

Table 58. Danisco Introduction and Business Overview

Table 59. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 60. Danisco Natamycin Product Offerings

Table 61. Danisco Recent Development

Table 62. DSM Company Information

Table 63. DSM Introduction and Business Overview

Table 64. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 65. DSM Natamycin Product Offerings

Table 66. DSM Recent Development

Table 67. VGP Company Information

Table 68. VGP Introduction and Business Overview

Table 69. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 70. VGP Natamycin Product Offerings

Table 71. VGP Recent Development

Table 72. Handary Company Information

Table 73. Handary Introduction and Business Overview

Table 74. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 75. Handary Natamycin Product Offerings

Table 76. Handary Recent Development

Table 77. AMTECH BIOTECH Company Information

Table 78. AMTECH BIOTECH Introduction and Business Overview

Table 79. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 80. AMTECH BIOTECH Natamycin Product Offerings

Table 81. AMTECH BIOTECH Recent Development

Table 82. Silver-Elephant Company Information

Table 83. Silver-Elephant Introduction and Business Overview

Table 84. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 85. Silver-Elephant Natamycin Product Offerings

Table 86. Silver-Elephant Recent Development

Table 87. Lanzhou Weiri Company Information

Table 88. Lanzhou Weiri Introduction and Business Overview

Table 89. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 90. Lanzhou Weiri Natamycin Product Offerings

Table 91. Lanzhou Weiri Recent Development

Table 92. Langfang Meihua Company Information

Table 93. Langfang Meihua Introduction and Business Overview

Table 94. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 95. Langfang Meihua Natamycin Product Offerings

Table 96. Langfang Meihua Recent Development

Table 97. Zhengzhou New Frey Company Information

Table 98. Zhengzhou New Frey Introduction and Business Overview

Table 99. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 100. Zhengzhou New Frey Natamycin Product Offerings

Table 101. Zhengzhou New Frey Recent Development

Table 102. Chihon Company Information

Table 103. Chihon Introduction and Business Overview

Table 104. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 105. Chihon Natamycin Product Offerings

Table 106. Chihon Recent Development

Table 107. Jiaozuo Joincare Company Information

Table 108. Jiaozuo Joincare Introduction and Business Overview

Table 109. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 110. Jiaozuo Joincare Natamycin Product Offerings

Table 111. Jiaozuo Joincare Recent Development

Table 112. Beijing Oriental Rada Company Information

Table 113. Beijing Oriental Rada Introduction and Business Overview

Table 114. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 115. Beijing Oriental Rada Natamycin Product Offerings

Table 116. Beijing Oriental Rada Recent Development

Table 117. Pucheng Lifecome Company Information

Table 118. Pucheng Lifecome Introduction and Business Overview

Table 119. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 120. Pucheng Lifecome Natamycin Product Offerings

Table 121. Pucheng Lifecome Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Natamycin Downstream Customers

Table 125. Natamycin Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Natamycin Product Picture

Figure 2. Global Natamycin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Natamycin Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Natamycin Sales Volume (2019-2030) & (MT)

Figure 5. Global Natamycin Sales Price (2019-2030) & (USD/MT)

Figure 6. Natamycin Report Years Considered

Figure 7. Global Natamycin Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Natamycin Players Sales Volume Ranking (2023) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Natamycin Revenue in 2023

Figure 10. Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Glucose-based Picture

Figure 12. Lactose-based Picture

Figure 13. Sodium chloride-based Picture

Figure 14. Global Natamycin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Natamycin Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Natamycin Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)

Figure 17. Global Natamycin Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Natamycin Price by Type (2019-2030) & (USD/MT)

Figure 19. Product Picture of Food

Figure 20. Product Picture of Medical

Figure 21. Product Picture of Others

Figure 22. Global Natamycin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Natamycin Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Natamycin Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)

Figure 25. Global Natamycin Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Natamycin Price by Application (2019-2030) & (USD/MT)

Figure 27. North America Natamycin Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Natamycin Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Natamycin Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Natamycin Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Natamycin Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Natamycin Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Natamycin Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Natamycin Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Natamycin Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Natamycin Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Natamycin Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Natamycin Sales Volume (%), (2019-2030)

Figure 39. United States Natamycin Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Natamycin Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Natamycin Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Natamycin Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Natamycin Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Natamycin Sales Value by Application (%), 2023 VS 2030

Figure 45. China Natamycin Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Natamycin Sales Value by Type (%), 2023 VS 2030

Figure 47. China Natamycin Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Natamycin Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Natamycin Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Natamycin Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Natamycin Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Natamycin Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Natamycin Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Natamycin Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Natamycin Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Natamycin Sales Value by Application (%), 2023 VS 2030

Figure 57. India Natamycin Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Natamycin Sales Value by Type (%), 2023 VS 2030

Figure 59. India Natamycin Sales Value by Application (%), 2023 VS 2030

Figure 60. Natamycin Industrial Chain

Figure 61. Natamycin Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions